2020-5-1 Archives - International Journal of Molecular and Immuno Oncology

Year: 2020, Volume: 5, Issue: 1, January-April

Article figure

Editorial

Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!

H. S. Darling, Alok Gupta

DOI: 10.25259/IJMIO_23_2019

Full text | PDF

p.1-7

Article figure

Original Article

Evaluation of prevalence and prognostic significance of human epidermal growth factor receptor 2/neu expression in carcinoma endometrium

Bhawani Shekhar, Sunesh Kumar, Sandeep Mathur, Seema Singhal, Jyoti Meena, D. N. Sharma, Neeta Singh

DOI: 10.25259/IJMIO_20_2019

Full text | PDF

p.8-13

Article figure

Review Article

Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review

Sunil Pasricha, Smita Asthana, Satyanarayana Labani, Uma Kailash, Abhinav Srivastav, Gurudutt Gupta, Anurag Mehta, Meenakshi Kamboj

DOI: 10.25259/IJMIO_17_2019

Full text | PDF

p.14-26

Article figure

Review Article

Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology

Sarma Subrot

DOI: 10.25259/IJMIO_18_2019

Full text | PDF

p.27-34

Article figure

Case Report

Chronic myelomonocytic leukemia-1 in a post-renal transplant patient

Priyanka Srivastava, Umapati Hegde, Shailesh Soni, Tejindar Singh

DOI: 10.25259/IJMIO_24_2019

Full text | PDF

p.35-38

© Copyright 2024 – International Journal of Molecular and Immuno Oncology.
Published by Scientific Scholar on behalf of Molecular Oncology Society and Immuno Oncology Leadership Network.

ISSN (Online): 2456-3994
ISSN (Print): 2836-3779